Chinese biological medicine start-up JOINN Biologics has raised US$60 million in a series A round of financing led by the country’s private equity investment firm Huagai Capital. Chaosheng Capital, China Union Holdings Ltd. and Suzhou Xiangtang Venture Capital also participated in this round. Proceeds of this round will be used for the construction of 100,000-liter-capacity […]

Huagai Capital Leads $60M Series A Round In Chinese Biological Medicine Start-up comes originally from China Money Network. All Rights Reserved.